Citigroup Inc Third Harmonic Bio, Inc. Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 15,843 shares of THRD stock, worth $82,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,843

Previous 20,312 22.0%

Holding current value

$82,066

Previous $209,000 74.16%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$3.25 - $11.17 $14,524 - $49,918	-4,469 Reduced 22.0%	15,843 $54,000
Q4 2024 Feb 12, 2025	BUY	$10.29 - $15.4 $39,132 - $58,566	3,803 Added 23.04%	20,312 $209,000
Q3 2024 Nov 12, 2024	BUY	$10.86 - $15.0 $119,948 - $165,675	11,045 Added 202.14%	16,509 $223,000
Q2 2024 Aug 12, 2024	BUY	$8.74 - $15.54 $13,284 - $23,620	1,520 Added 38.54%	5,464 $71,000
Q1 2024 May 10, 2024	BUY	$8.6 - $11.24 $3,156 - $4,125	367 Added 10.26%	3,944 $37,000
Q4 2023 Feb 09, 2024	BUY	$5.97 - $11.47 $21,300 - $40,924	3,568 Added 39644.44%	3,577 $39,000
Q3 2023 Nov 09, 2023	SELL	$4.92 - $7.09 $28,496 - $41,065	-5,792 Reduced 99.84%	9 $0
Q2 2023 Aug 10, 2023	BUY	$4.18 - $5.33 $24,248 - $30,919	5,801 New	5,801 $27,000
Q4 2022 Feb 09, 2023	BUY	$4.0 - $23.97 $1,656 - $9,923	414 New	414 $1,000

Others Institutions Holding THRD

# of Institutions

Shares Held

38.5M

Call Options Held

76.6K

Put Options Held

22.8K

View Full List

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $209M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account